Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 7
2022 8
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler P, Grittner U, Oechtering J, Leppert D, Siebert N, Duchow AS, Oertel FC, Asseyer S, Kuchling J, Zimmermann HG, Brandt AU, Benkert P, Reindl M, Jarius S, Paul F, Bellmann-Strobl J, Kuhle J, Ruprecht K. Schindler P, et al. Among authors: duchow as. J Neuroinflammation. 2021 May 1;18(1):105. doi: 10.1186/s12974-021-02138-7. J Neuroinflammation. 2021. PMID: 33933106 Free PMC article.
[Autoimmune encephalitis-An update].
Heine J, Duchow A, Rust R, Paul F, Prüß H, Finke C. Heine J, et al. Among authors: duchow a. Nervenarzt. 2022 Dec 14:1-12. doi: 10.1007/s00115-022-01411-1. Online ahead of print. Nervenarzt. 2022. PMID: 36515716 Free PMC article. Review. German.
Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis.
Müller J, Sinnecker T, Wendebourg MJ, Schläger R, Kuhle J, Schädelin S, Benkert P, Derfuss T, Cattin P, Jud C, Spiess F, Amann M, Lincke T, Barakovic M, Cagol A, Tsagkas C, Parmar K, Pröbstel AK, Reimann S, Asseyer S, Duchow A, Brandt A, Ruprecht K, Hadjikhani N, Fukumoto S, Watanabe M, Masaki K, Matsushita T, Isobe N, Kira JI, Kappos L, Würfel J, Granziera C, Paul F, Yaldizli Ö. Müller J, et al. Among authors: duchow a. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 25;9(3):e1147. doi: 10.1212/NXI.0000000000001147. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35217580 Free PMC article.
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCENMO Study.
Hümmert MW, Schöppe LM, Bellmann-Strobl J, Siebert N, Paul F, Duchow A, Pellkofer H, Kümpfel T, Havla J, Jarius S, Wildemann B, Berthele A, Bergh FT, Pawlitzki M, Klotz L, Kleiter I, Stangel M, Gingele S, Weber MS, Faiss JH, Pul R, Walter A, Zettl UK, Senel M, Stellmann JP, Häußler V, Hellwig K, Ayzenberg I, Aktas O, Ringelstein M, Schreiber-Katz O, Trebst C; Neuromyelitis Optica Study Group (NEMOS). Hümmert MW, et al. Among authors: duchow a. Neurology. 2022 Mar 15;98(11):e1184-e1196. doi: 10.1212/WNL.0000000000200052. Epub 2022 Jan 26. Neurology. 2022. PMID: 35082170 Free PMC article.
Emerging drugs for the treatment of neuromyelitis optica.
Duchow A, Chien C, Paul F, Bellmann-Strobl J. Duchow A, et al. Expert Opin Emerg Drugs. 2020 Sep;25(3):285-297. doi: 10.1080/14728214.2020.1803828. Epub 2020 Aug 25. Expert Opin Emerg Drugs. 2020. PMID: 32731771 Review.
18 results